MOTIONIQ IMAGING · ADVANCED SPINAL MOTION DIAGNOSTICS

Vertebral Motion Analysis®

Dynamic imaging to measure spinal motion, ligament integrity and instability. Objective testing for real impact: accurate, reliable, defensible.

Learn about VMA®
Authorized Driving Force VMA® distributor · San Antonio & surrounding areas

OBJECTIVE TESTING FOR REAL IMPACT

Vertebral Motion Analysis — VMA®

Dynamic imaging to measure spinal motion, ligament integrity and instability. An FDA-cleared, motion-based technology that analyzes spinal movement frame by frame under controlled bending.

Objective Measurement

Quantifies abnormal spinal motion and instability.

Real-Time Dynamic Imaging

Captures motion during controlled bending not seen on standard MRI or static X-rays.

Valuable Evidence

Supports injury documentation, causation and case value.

MotionIQ Vertebral Motion Analysis flyer

VMA® REPORT EXAMPLES

Quantified, defensible data

CERVICAL TRANSLATION SUMMARY (mm)

LevelNeutralFlexionExtension
C3/C40.41.1 0.9
C4/C50.62.3 1.4
C5/C60.53.1 1.8
C6/C70.72.6 1.2

LUMBAR MOTION ANALYSIS SUMMARY

LevelMax Trans.Δ ViewsMax Ang. (F/E)
L1/L21.2mm 0.4mm8° / 6°
L2/L31.5mm 0.6mm10° / 7°
L3/L42.1mm 1.1mm12° / 9°
L4/L53.4mm 2.0mm15° / 11°
L5/S12.8mm 1.5mm13° / 10°
Potential mal-alignment or excessive motion Potential borderline mal-alignment or excessive motion

Key Advantages

  • Detects injuries often missed on standard MRI or X-rays.
  • Quantifies motion and instability.
  • Provides clear, visual evidence for attorneys and insurance companies.
  • Helps establish causation and permanency (per AMA Guidelines).
  • Supports higher case value and improved settlement outcomes.
Non-Invasive Outpatient Testing
Fast Scheduling & Timely Reports
Objective Data That Strengthens Cases

OBJECTIVE TREATMENT RESPONSE

Before & after treatment outcomes

VMA quantifies treatment response by comparing segmental motion before and after intervention, giving clinicians and attorneys defensible evidence of efficacy that subjective pain scales cannot.

BEFORE TREATMENT
-3.1 mm (-22%)

Sagittal Translation (Extension) at C5/C6

AFTER TREATMENT
-1.2 mm (-8%)

Returned to normal range

Following a 12-week targeted stabilization protocol, cervical translation at C5/C6 reduced from -3.1 mm (-22%) to -1.2 mm (-8%), moving the patient from a flagged excessive-motion threshold back within normal range. Static imaging showed no structural change across the same period.

Cervical motion, visualized in real time

VMA® captures dynamic fluoroscopic motion of the cervical spine through full flexion and extension, revealing segmental translation and rotation that static imaging can miss.

REC · C-SPINE
FLUORO 30fps
LATERAL · FLEX/EXT
kV 75 · mA 4

FROM MOTION TO MEDICAL EVIDENCE

VMA® report examples

Detailed, measurable data with clear visual analysis.

Cervical Translation Summary (mm)
LevelNeutralFlexionExtension
C3/C4-0.5-0.2-0.4
C4/C50.31.1-1.5
C5/C6-2.6-1.4-3.1
C6/C7-1.4-1.0-1.0

Highlighted values indicate potential mal-alignment or excessive motion.

Key advantages of VMA®

  • Detects injuries often missed on standard MRI or X-rays
  • Quantifies motion and instability
  • Provides clear, visual evidence for attorneys and insurance companies
  • Helps establish causation and permanency (per AMA Guidelines)
  • Supports higher case value and improved settlement outcomes

POWERED BY DRIVING FORCE

MotionIQ Imaging is your Driving Force VMA® distributor

We bring Driving Force's FDA-cleared Vertebral Motion Analysis technology to practices and attorneys in San Antonio and surrounding areas, with fast scheduling and timely reports.

  • Patented real-time tracking of each vertebra through full ranges of motion
  • Weight-bearing motion platforms with reproducible flexion and extension arcs
  • Automated diagnostic analysis with segment-specific findings
Learn more at drivingforcecompany.com →
VMA® EXCLUSIVITY
San Antonio
and surrounding areas
Accurate.Reliable.Defensible.

LEADERSHIP

Meet the managing partners

RS

Roberto Solis

President · Managing Partner

CG

Christopher Gutierrez

COO · Managing Partner

Objective testing for real impact

Non-invasive outpatient testing. Direct-pay pricing with no LOP required.

www.motioniqimaging.com

© MotionIQ Imaging. VMA® is a registered trademark of its owner; MotionIQ Imaging is a Driving Force distributor.